Louise Tofts

Once-daily, subcutaneous vosoritide therapy in children with achondroplasia: a randomised, double-blind, phase 3, placebo-controlled, multicentre trial

Ravi Savarirayan, Louise Tofts, Melita Irving et al. · The Lancet · 2020 · 184 citations

Subcutaneous Vosoritide Therapy, Pediatrics, Multicentre Trial +2

Safe and persistent growth-promoting effects of vosoritide in children with achondroplasia: 2-year results from an open-label, phase 3 extension study

Ravi Savarirayan, Louise Tofts, Melita Irving et al. · Genetics in Medicine · 2021 · 88 citations · Full text

Quality of life prediction in children with joint hypermobility syndrome

Verity Pacey, Louise Tofts, Roger Adams et al. · Journal of Paediatrics and Child Health · 2015 · 73 citations

The natural history of children with joint hypermobility syndrome and Ehlers–Danlos hypermobility type: a longitudinal cohort study

Mark Scheper, Lesley L. Nicholson, Roger Adams et al. · Lara D. Veeken · 2017 · 58 citations · Full text

Generalized Hyperalgesia in Children and Adults Diagnosed With Hypermobility Syndrome and Ehlers‐Danlos Syndrome Hypermobility Type: A Discriminative Analysis

Mark Scheper, Verity Pacey, Lies Rombaut et al. · Arthritis Care & Research · 2016 · 57 citations · Full text